From: Survival prediction in acute myeloid leukemia using gene expression profiling
 | The TCGA dataset | The OHSU dataset | |||||
---|---|---|---|---|---|---|---|
Variable | OR | 2.5%-97.5%CI | P value | Variable | OR | 2.5–97.5%CI | P value |
Age | 1.02 | 1.01–1.04 | 0.004 | Age | 1.02 | 1.01–1.03 | < 0.001 |
Cytogenetics risk | 1.07 | 0.71–1.62 | 0.75 | Cytogenetics risk | 1.16 | 0.96–1.41 | 0.13 |
TP53.mutation | 1.47 | 0.76–2.86 | 0.25 | Chemotherapy | 0.4 | 0.22–0.71 | 0.002 |
Risk score | 5.25 | 3.16–8.71 | < 0.001 | Transplant | 0.42 | 0.29–0.6 | < 0.001 |
 |  |  |  | Targeted therapy | 0.91 | 0.66–1.26 | 0.58 |
 |  |  |  | TP53.mutation | 2.32 | 1.5–3.57 | < 0.001 |
 |  |  |  | Risk score | 1.87 | 1.4–2.49 | < 0.001 |